Multiple Antigen-Engineered DC Vaccine for Melanoma

NCT01622933 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

35

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

BIOLOGICAL: DC Vaccine + IFN
BIOLOGICAL: AdVTMM2/DC Vaccination

Sponsor

Lisa H. Butterfield, Ph.D.

Collaborators

[object Object]